Tyro Capital Management LLC Portfolio
Auto-discovered 13F filer (Top-2000 by latest reported value).
SEC 13F CIK: 0001915395
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Q4 2025 · 12 positions · Total reported value $337.23M · Top-10 concentration 95.2% · Updated 2026-10-18
Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR
Turnover: 59.4% · 17 new · 1 cut · 1 exited
Active Share (vs S&P 500): 98.0% · vs QQQ: 96.5% — share of the book that differs from index weights (higher = more active) · ranking
In its Q4 2025 13F filing, Tyro Capital Management LLC disclosed 12 equity positions with a combined reported value of $337.23M. The filing implies a focused portfolio: its ten largest positions account for 95.2% of reported value. HoldingsHub classifies the profile as Small / Focused / High Turnover.
The largest disclosed positions as of Q4 2025 were ESTA ($72.88M), CRH ($45.11M), SN ($40.07M). By sector, the heaviest allocations are Health Care 34.4%, Consumer Discretionary 31.1%. Versus the prior quarter, allocation shifted toward Health Care (+16.2pp), Consumer Staples (+4.0pp) and away from Industrials (-4.8pp), Technology (-5.8pp).
Versus the prior quarter, Tyro Capital Management LLC opened 17 new positions, trimmed 1 and fully exited 1, a turnover rate of 59.4% of positions. The portfolio's overlap with the prior quarter was 47% of names.
The largest new positions opened in Q4 2025 were SPRY ($23.24M), QURE ($15.89M), CELH ($13.59M).
Of the 1 positions fully exited versus the prior quarter, the largest were GRPN ($25.48M), HNGE ($15.66M), LENZ ($4.69M).
Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.
New Positions (Q4 2025)
- SPRY ARS PHARMACEUTICALS INC · $23.24M
- QURE UNIQURE NV · $15.89M
- CELH CELSIUS HLDGS INC · $13.59M
- LULU LULULEMON ATHLETICA INC · $12.19M
- CYTK Cytokinetics, Incorporated · $3.85M
Insider Transactions (Form 4)
Latest Tyro Capital Management LLC buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.
No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.
Fund Profile
Tyro Capital Management LLC is an SEC-registered 13F filer based in Miami, FL, United States. As of Q2 2026 it reported 15 US equity positions with a combined value of $445.67M. HoldingsHub carries 11 quarters of its filings (Q4 2023–Q2 2026).
Firm Snapshot
- Headquarters: MIAMI, FL, United States
- SEC registration: 801-128575 (status: Approved), registered 2023-08-11
- Regulatory AUM (Form ADV): $570.91M as of 2026-04-16
- Client mix (by RAUM): pension and profit-sharing plans 100%
- Manages 2 private funds, of which 2 hedge funds
Portfolio Structure
- 15 positions · $445.67M reported value (Q2 2026)
- Top 10 holdings = 82.8% of reported value
- Largest position: ESTA (ESTABLISHMENT LABS HLDGS INC) at 11.7%
- Average position size: $29.71M
Sector Tilt
- Health Care 31.0%
- Industrials 30.1%
- Consumer Discretionary 15.9%
- (classified holdings cover 100% of value)
Quarterly Activity
- Q2 2026: 4 new, 6 added, 5 reduced, 14 exited
Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.
Sector Allocation
| # | Company | Shares | Value | Weight | Allocation | Change |
|---|---|---|---|---|---|---|
| 1 |
|
1.00M | $72.88M | 21.61% | Reduce | |
| 2 |
|
361.49K | $45.11M | 13.38% | Hold | |
| 3 |
|
358.08K | $40.07M | 11.88% | Add | |
| 4 |
|
126.60K | $39.86M | 11.82% | Hold | |
| 5 |
|
363.52K | $31.09M | 9.22% | Add | |
| 6 |
|
1.99M | $23.24M | 6.89% | New | |
| 7 |
|
1.00M | $21.56M | 6.39% | Add | |
| 8 |
|
164.94K | $17.90M | 5.31% | Hold | |
| 9 |
|
663.93K | $15.89M | 4.71% | New | |
| 10 |
|
297.16K | $13.59M | 4.03% | New | |
| 11 |
|
58.64K | $12.19M | 3.61% | New | |
| 12 |
|
60.64K | $3.85M | 1.14% | New | |
FAQ
What did Tyro Capital Management LLC buy in 2025-Q4?
In its 2025-Q4 13F filing, Tyro Capital Management LLC reported 12 equity positions worth $337.23M in aggregate; its largest disclosed positions were ESTA ($72.88M), CRH ($45.11M), SN ($40.07M).
How large is Tyro Capital Management LLC's portfolio?
Tyro Capital Management LLC reported $337.23M of long equity holdings across 12 positions as of 2025-Q4. Top-10 holdings account for 95.2% of reported value.
What is Tyro Capital Management LLC's investment style?
HoldingsHub classifies the portfolio as Small / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.
Where does this data come from?
All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.